Hiv envelope
Antigenic Properties of the HIV Envelope on Virions in Solution
15
Effect of HIV Envelope Vaccination on the Subsequent Antibody Response to HIV Infection
13
Molecular Evolution: The HIV Envelope Protein
5
The frantic play of the concealed HIV envelope cytoplasmic tail
24
Positive Selection at Key Residues in the HIV Envelope Distinguishes Broad and Strain-Specific Plasma Neutralizing Antibodies
16
The membrane spanning domain of gp41 plays a critical role in intracellular trafficking of the HIV envelope protein
12
Apoptosis of uninfected cells induced by HIV envelope glycoproteins
12
Effect of nonprotective vaccination on antibody response to subsequent human immunodeficiency virus infection
8
Excretion of Human Immunodeficiency Virus Type 1 through Polarized Epithelium by Immunoglobulin A
10
Nonneutralizing Functional Antibodies: a New “Old” Paradigm for HIV Vaccines
14
Broadly neutralizing antibodies targeted to mucin-type carbohydrate epitopes of human immunodeficiency virus.
7
Strategies for an HIV vaccine
7
Determining Human Immunodeficiency Virus Coreceptor Use in a Clinical Setting: Degree of Correlation between Two Phenotypic Assays and a Bioinformatic Model
6
Common Themes of Antibody Maturation to Simian Immunodeficiency Virus, Simian-Human Immunodeficiency Virus, and Human Immunodeficiency Virus Type 1 Infections
8
Expression and Immunogenicity of Human Immunodeficiency Virus Type 1 Gag Expressed by a Replication-Competent Rhabdovirus-Based Vaccine Vector
9
Adaptive Evolution of the SIV Envelope Protein During Early SIV Infection
186
HIV 1 envelope, integrins and co receptor use in mucosal transmission of HIV
10
The human immunodeficiency virus (HIV) type 2 envelope protein is a functional complement to HIV type 1 Vpu that enhances particle release of heterologous retroviruses.
16
Release of gp120 Restraints Leads to an Entry Competent Intermediate State of the HIV 1 Envelope Glycoproteins
12
Hypothesis of snake and insect venoms against Human Immunodeficiency Virus: a review
5